This website is no longer being updated. Please visit GBCHealth’s new website at: www.gbchealth.org.

MEMBER PROFILES

Lafarge

Company Overview

Located in 64 countries with 68,000 employees, Lafarge is a world leader in building materials with top-ranking positions in its Cement, Aggregates & Concrete businesses. In 2011 Lafarge posted sales of 15.3 billion euros.

For the second year in a row, Lafarge ranked amongst the top10 of 500 companies evaluated by the “Carbon Disclosure Project” in recognition of its strategy and actions against global warming.  With the world’s leading building materials research facility, Lafarge places innovation at the heart of its priorities, working towards sustainable construction and architectural creativity.  

Additional information is available on the web site at www.lafarge.com

Health Program Overview

Health at Lafarge - A number one priority

Lafarge ranks health as its top priority and has maintained the same ambition for over 10 years: to be among the safest and the healthiest companies in the world. To achieve this goal, the Group focuses on:

  • Health at work
  • Public health

Maintaining employees' health

Lafarge has developed a health strategy for all its sites which is based on three pillars:

  • Prevention: all Lafarge sites must manage employees' exposure to health risks (dust, noise, use of chemicals, ergonomics, etc.)
  • First aid and reintegration in case of illness or accident through:
    • First aid trainings,
    • Emergency treatment rooms and sometimes clinics built where access to healthcare is difficult.
    • Work positions adapted to employees' level of incapacity.
  • Promotion of a healthy life style (nutrition, physical effort, well-being, preventing diseases).

Acting locally for everyone's health

Lafarge is also involved in public health initiatives. This approach dates back to 2001 when the Group implemented its first HIV/AIDS prevention and treatment program in sub-Saharan Africa.

Since then, the Group takes advantage of this positive experience to enlarge its programs to other illnesses and to adapt them to local issues, such as the fight against malaria or tuberculosis in African countries and diabetes and alcohol-related issues in Europe and North America. And in some countries where access to medical and healthcare facilities is more difficult, Lafarge goes beyond its plants to make its health programs available to local community members.

HIV/AIDS Profile

Fighting AIDS for employees and communities

Lafarge committed to fighting AIDS in the region in 2001. It was the first French company to join the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) in 2002.

Lafarge set up the Pilot Project in 2002, which evaluated the impact of HIV/AIDS on Lafarge's business in sub-Saharan Africa. It established best practices and guidelines for management teams and employees.

In 2003, Lafarge published its HIV/AIDS Guidelines, which implemented nondiscrimination and confidentiality policies. The Group formulated these guidelines in collaboration with:

  • unions (International Federation of Building and Wood Workers, World Federation of Building and Wood Workers),
  • non governmental organizations (CARE),
  • companies (Private Investors for Africa, Global Business Coalition on HIV/Aids, Tuberculosis and Malaria, National Business Coalitions)
  • International and bilateral organizations, such as USAID or GTZ

Lafarge created two Road Maps based on local best practices and the experience of Private Investors for Africa member companies. The Road Maps monitor and evaluate the Group's HIV/AIDS and Malaria program.

Lafarge's HIV/AIDS program includes:

  • Education: educational literature and peer educators who build awareness and encourage their colleagues to act responsibly.
  • Prevention: distribution of free condoms
  • Free, anonymous, Voluntary Counseling and Testing
  • Care and Treatment: free anti retroviral (ARV) medication and opportunistic disease treatment.

As a result of these measures, in 2007:

  • 100% of employees in sub-Saharan Africa received regular information about HIV,
  • 75% participated in VCT campaigns,
  • Over 2000 people (employees, dependants and community members) benefited from ARV treatment.

The success of Lafarge's HIV/AIDS program is largely due to partnerships with unions, families, schools, companies, governmental organizations and NGOs. The Group has expanded its workplace program to local communities through partnerships with:

  • the Global Fund to Fight AIDS, Tuberculosis and Malaria in Cameroon, Uganda and Malawi
  • German Technical Cooperation (GTZ) in Kenya, Malawi, and Nigeria,
  • United States Agency for International Development (USAID) in Uganda and Nigeria

CARE

Since 2003, Lafarge has worked alongside CARE, one of the largest human development NGOs, in the struggle against HIV/AIDS. CARE is a member of Lafarge's Africa Health Committee, which selects indicators, coordinates actions and shares best practices. In addition to a CARE representative, the committee includes a health coordinator from each subsidiary, a Group representative, and a medical adviser.

Malaria Profile

Using anti-AIDS methodology to fight malaria

Malaria kills one person every 30 seconds and significantly hampers Africa's economic development. It causes on average a third of Lafarge employee absenteeism in Africa. The Group has been combating the disease since 2006. Lafarge has developed a malarial prevention and health program inspired directly by the methodology used to combat AIDS, which includes:

  • information and prevention campaigns,
  • distribution of free insecticide treated mosquito nets treated to employees and their dependant
  • Vector Control Measures (Larval control, Indoor Residual Spraying)
  • Intermittent Presumptive Treatment for pregnant women,
  • anti-malarial treatment following systematic biological diagnosis

Lafarge's partners in the fight against malaria include:

  • Population Services International (PSI) in Malawi and Zambia, Society For Family Health in Nigeria
  • Health Initiative in the Private Sector (USAID funded HIPS) in Uganda
  • Friends of the Global Fund Europe in Benin.